Status:
COMPLETED
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Dyslipidemia
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
This study will investigate the effect of MK0859 on lipoprotein metabolism in patients with dyslipidemia already on statin therapy.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient's weight has been stable for at least 6 weeks
- Patient is in good health based on medical history, physical exam, and laboratory tests
- Patient has dyslipidemia
- Exclusion Criteria :
- Patient has a history of stroke, seizures, or major neurological disorders
- Patient has a history of cancer
- Patient is currently taking any lipid-lowering medications or substances except for statins
- Patient consumes excessive amounts of alcohol or caffeine
- Patient has multiple and/or severe allergies to food or drugs
Exclusion
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00990808
Start Date
November 1 2009
End Date
July 1 2011
Last Update
June 4 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.